1. Role of kidney biomarkers of chronic kidney disease: An update
   Zeba Khan et al, 2014, Saudi Journal of Biological Sciences CrossRef
2. The cytoskeleton as a novel target for treatment of renal fibrosis
   Alan R. Parrish, 2016, Pharmacology & Therapeutics CrossRef
3. Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury
   Youqun Huang et al, 2014, BMC Nephrology CrossRef
4. Expression analysis of microRNA-155 in type 2 diabetes in Kashmiri population
   Misbah Majid et al, 2020, International Journal of Diabetes in Developing Countries CrossRef
5. MicroRNA‐326‐3p ameliorates high glucose and ox‐LDL‐IC‐ induced fibrotic injury in renal mesangial cells by targeting FcγRIII
   Yiting Wang et al, 2018, Nephrology CrossRef
6. Role of DDAH/ADMA pathway in TGF-β1-mediated activation of hepatic stellate cells
   Zhenguo Liu et al, 2017, Molecular Medicine Reports CrossRef
7. Asymmetric dimethylarginine: An crucial regulator in tissue fibrosis
   Wei-Chen Zhao et al, 2019, European Journal of Pharmacology CrossRef